Table 8 Biodistribution of radioactivity after i.v. injection of [18F]NaF in micea.
From: Evaluation of Ga-DOTA-(D-Asp)n as bone imaging agents: D-aspartic acid peptides as carriers to bone
Tissue | Time after injection | ||
|---|---|---|---|
10āmin | 60āmin | 180āmin | |
Blood | 1.78 (0.23) | 0.11 (0.04) | 0.02 (0.00) |
Liver | 1.34 (0.17) | 0.09 (0.02) | 0.02 (0.00) |
Kidney | 5.23 (2.31) | 1.13 (0.89) | 0.15 (0.08) |
Small-intestine | 1.31 (0.22) | 0.68 (0.10) | 0.06 (0.02) |
Large-intestine | 0.95 (0.22) | 1.21 (0.27) | 1.39 (0.19) |
Spleen | 1.10 (0.15) | 0.08 (0.02) | 0.02 (0.00) |
Pancreas | 0.87 (0.15) | 0.08 (0.08) | 0.02 (0.03) |
Lung | 1.44 (0.19) | 0.10 (0.03) | 0.03 (0.01) |
Heart | 1.84 (0.41) | 0.15 (0.05) | 0.02 (0.01) |
Stomachb | 0.36 (0.04) | 0.06 (0.02) | 0.13 (0.14) |
Bone (Femur) | 27.69 (3.15) | 39.96 (2.52) | 43.91 (2.64) |
Muscle | 0.83 (0.13) | 0.07 (0.04) | 0.01 (0.01) |
Brain | 0.10 (0.02) | 0.36 (0.52) | 0.05 (0.02) |
F/B ratioc | 15.59 (1.01) | 381.63 (84.17) | 1983.88 (256.88) |